Work Productivity and Activity Impairment in Breast Cancer Patients Treated with Capecitabine

Marco Vacante, Giulia Malaguarnera, Manuela Pennisi, Giuseppe Grosso, Salvatore Salomone, Filippo Drago, Erdogan Ozyalcin, Vito Catania, Alfredo Consoli, Mariano Malaguarnera

Department of General Surgery, University of Catania, Catania, Italy.
Department of Neurosciences, University of Catania, Catania, Italy.
International PhD Programme in Neuropharmacology, University of Catania, Catania, Italy.
Research Center “The Great Senescence”, Cannizzaro Hospital, University of Catania, Catania, Italy.

DOI: 10.4236/jct.2013.47142                

Abstract

Background: Although the majority of breast cancer patients are able to work, lower work ability and reduced job retention have been reported. The aim of the present study was to evaluate the effect of chemotherapy with capecitabine in patients with breast cancer on work productivity and daily activity. Methods: 34 patients with metastatic breast cancer were enrolled for our study. Capecitabine was given twice daily at a cumulative dose of 2500 mg/m² on days 1 - 14 and repeated on day 22. Work productivity was determined using the WPAI questionnaire. Results: We observed an increase in absenteeism, presenteeism, work productivity loss and daily activity impairment after 1 cycle and 6 cycles of therapy, but we could not find statistically different significances. Conclusions: This study provides some data indicating an association between problems in breast cancer and work. Our results confirm that capecitabine may improve quality of life of patients with metastatic breast cancer.

Keywords

Breast Cancer; Capecitabine; Work Productivity; Absenteeism; Presenteeism

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	P. M. Hoff and R. Pazdur, “Dihydropyrimidine Dehydrogenase Inhibitory Fluoropyrimidines: A Novel Class of Oral Antineoplastic Agents,” Seminars in Oncology, Vol. 26, No. 6, 1999, pp. 52-56.
[2]	J. Schüller, J. Cassidy, E. Dumont, B. Roos, S. Durston, L. Banken, M. Utoh, K. Mori, E. Weidekamm and B. Reigner, “Preferential Activation of Capecitabine in Tumor Following Oral Administration to Colorectal Cancer Patients,” Cancer Chemotherapy and Pharmacology, Vol. 45, No. 4, 2000, pp. 291-297. doi:10.1007/s002800050043
[3]	G. Malaguarnera, M. Pennisi, G. Grosso, M. Vacante, S. Salomone, F. Drago, M. Malaguarnera, E. Ozyalcin, M. Motta, V. Raciti and M. Malaguarnera, “Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine,” Journal of Cancer Therapy, Vol. 4, No. 7, 2013.
[4]	J. E. Lavigne, J. J. Griggs, X. M. Tu and D. J. Lerner, “Hot Flashes, Fatigue, Treatment Exposures and Work Productivity in Breast Cancer Survivors,” Journal of Cancer Survivorship, Vol. 2, No. 4, 2008, pp. 296-302. doi:10.1007/s11764-008-0072-z
[5]	P. Maguire, M. Brooke, A. Tait, C. Thomas and R. Sellwood, “The Effect of Counselling on Physical Disability and Social Recovery after Mastectomy,” Clinical Oncology, Vol. 9, 1983, pp. 319-324.
[6]	National Cancer Institute Common Toxicity Criteria (NCI-CTC), Version 2.0, DCTD, NCI, NIH, DHHS, March 1998.
[7]	M. C. Reilly, K. L. Gooch, R. L. Wong, H. Kupper and D. van der Heijde, “Validity, Reliability and Responsiveness of the Work Productivity and Activity Impairment Questionnaire in Ankylosing Spondylitis,” Rheumatology (Oxford), Vol. 49, No. 4, 2010, pp. 812-819.
[8]	S. A. Payne, “A Study of Quality of Life in Cancer Patients Receiving Palliative Chemotherapy,” Social Science and Medicine, Vol. 35, No. 12, 1992, pp. 1505-1509. doi:10.1016/0277-9536(92)90053-S
[9]	P. Frazzetto, M. Vacante, M. Malaguarnera, E. Vinci, F. Catalano, E. Cataudella, F. Drago, G. Malaguarnera, F. Basile and A. Biondi, “Depression in Older Breast Cancer Survivors,” BMC Surgery, Vol. 12, Suppl 1, 2012, p. S14. doi:10.1186/1471-2482-12-S1-S14
[10]	L. Freeman, “Peer Assistance. Focus on New Return-toWork Opportunities for Nurses in Recovery,” Texas Nursing, Vol. 70, 1996, pp. 2-3.
[11]	M. Malaguarnera, M. Vacante, P. M. Frazzetto and M. Motta, “What Is the Frailty in Elderly? Value and Significance of the Multidimensional Assessments,” Archives of Gerontology and Geriatrics, Vol. 56, No. 1, 2013, pp. 23-26. doi:10.1016/j.archger.2011.09.017
[12]	M. Vacante, V. D’Agata, M. Motta, G. Malaguarnera, A. Biondi, F. Basile, M. Malaguarnera, C. Gagliano, F. Drago and S. Salamone, “Centenarians and Supercentenarians: A Black Swan. Emerging Social, Medical and Surgical Problems,” BMC Surgery, Vol. 12, Suppl 1, 2012, p. S36. doi:10.1186/1471-2482-12-S1-S36
[13]	A. B. Schultz, C. Y. Chen and D. W. Edington, “The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature,” Pharmacoeconomics, Vol. 27, No. 5, 2009, pp. 365-378. doi:10.2165/00019053-200927050-00002
[14]	D. A. Adler, T. J. McLaughlin, W. H. Rogers, H. Chang, L. Lapitsky and D. Lerner, “Job Performance Deficits Due to Depression,” American Journal of Psychiatry, Vol. 163, No. 9, 2006, pp. 1569-1576. doi:10.1176/appi.ajp.163.9.1569
[15]	P. S. Wang, A. Beck, P. Berglund, J. A. Leutzinger, N. Pronk, D. Richling, T. W. Schenk, G. Simon, P. Stang, T. B. Ustun and R. C. Kessler, “Chronic Medical Conditions and Work Performance in the Health and Work Performance Questionnaire Calibration Surveys,” Journal of Occupational and Environmental Medicine, Vol. 45, No. 12, 2003, pp. 1303-1311. doi:10.1097/01.jom.0000100200. 90573.df
[16]	D. Lerner, D. A. Adler, H. Chang, L. Lapitsky, M. Y. Hood, C. Perissinotto, J. Reed, T. J. McLaughlin, E. R. Berndt and W. H. Rogers, “Unemployment, Job Retention and Productivity Loss among Employees with Depression,” Psychiatric Services, Vol. 55, No. 12, 2004, pp. 1371-1378. doi:10.1176/ appi.ps.55.12.1371